BioSpace News Archive

Laekna Therapeutics announced that the Center for Drug Evaluation, the National Medical Products Administration of China has approved the Investigational New Drug application of its Category 1 new drug candidate afuresertib in combination with anti-estrogen receptor drug fulvestrant in the Phase Ib/III clinical trial of patients with locally advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.

Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal disorders, announced the successful completion of a $60 million Series B crossover round led by Vivo Capital.

TCR2 Therapeutics Inc., a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, announced the appointment of Priti Hegde, Ph.D., to its Board of Directors.

NRx Pharmaceuticals announced today it has signed an agreement with Cardinal Health to provide third party logistics and distribution of ZYESAMI™ upon the potential Emergency Use Authorization (EUA) approval by the US Food and Drug Administration (FDA).

Pfizer Inc. and BioNTech SE announced the signing of a letter of intent with Eurofarma Laboratórios SA, a Brazilian biopharmaceutical company, to manufacture COMIRNATY® for distribution within Latin America.

BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed former director of the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), and former acting surgeon general, Steven Galson, M.D., MPH to its board of directors.

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced that preclinical data of ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome were published in the peer-reviewed journal, Scientific Reports.

Novartis Pharmaceuticals Canada Inc., in partnership with C2 International is hosting the first ever Biome Summit in Canada.

Today GSK launches its public health campaign, “Ask2BSure,” to encourage parents to talk with their child’s doctor to be sure if they have received meningitis B vaccination.

Compugen Ltd. today announced that management will present at the Morgan Stanley 19th Annual Global Healthcare Conference (virtual), on Thursday, September 9, 2021 at 11:00 am ET .